However, RASSF1A has no significant differences among stages of cancer, stage I (ΔCt = 7.2 ± 3.3) is 66.2%, stage II (ΔCt = 5.6 ± 3.5) is 56.5%, stage III (ΔCt = 5.9 ± 3.2) is 59.1% and stage IV (ΔCt = 5.6 ± 4.6) is 55.6%. Here, RASSF1 is linked to cancer.